The Czech Republic Annual Report 2010 Drug ... - Drogy-info.cz

Table 2-6: Prevalence rates of use of selected legal and illegal drugs among internet users aged 15–34 who had used
new synthetic drugs (legal highs), in % (Národní monitorovací středisko pro drogy a drogové závislosti and Median,
2011a)
Gender Age Total
Prevalence
Lifetime
prevalence
Prevalence in
the last 12
months
Prevalence in
the last 30 days
Drug
Males Females 15–24 25–34 15–34
(n=99) (n=52) (n=109) (n=42) (n=151)
Tobacco 94.0 94.2 94.5 92.8 94.0
Alcohol 100.0 100.0 99.9 100.0 100.0
Marijuana and hashish 90.0 96.1 92.7 90.5 92.1
Ecstasy 52.2 63.5 58.8 49.9 56.2
Amphetamines, pervitin 20.2 23.1 40.4 35.7 39.0
Cocaine 31.3 30.7 28.5 38.1 31.1
Heroin 15.1 19.2 16.5 16.7 16.6
LSD 30.3 48 50.4 26.2 31.8
Hallucinogenic mushrooms 43.5 48.1 45.0 52.3 45.0
Inhalants 21.2 26.9 24.8 19.0 23.1
Ketamine 17.2 19.2 19.2 14.3 17.8
Subutex ® 19.3 17.2 19.3 16.7 18.5
GHB 15.2 11.5 13.8 14.4 13.9
Poppers 27.3 17.3 23.9 23.7 23.8
Tobacco 85.9 86.5 88.1 80.9 86.1
Alcohol 99.0 98.1 98.1 100.0 98.7
Marijuana and hashish 71.8 69.2 71.6 69.1 70.9
Ecstasy 32.3 32.7 34.0 28.5 32.4
Amphetamines, pervitin 18.2 17.3 17.5 19.0 17.8
Cocaine 17.2 11.5 14.7 16.7 15.2
Heroin 7.0 7.7 5.5 11.9 7.3
LSD 16.2 13.4 16.5 11.9 15.2
Hallucinogenic mushrooms 16.2 23.1 19.3 23.7 18.5
Inhalants 10.1 7.7 8.3 11.9 9.2
Ketamine 9.1 5.7 7.3 9.5 7.9
Subutex ® 11.2 5.7 8.3 11.9 9.2
GHB 8.1 1.9 4.6 9.6 6.0
Poppers 18.2 7.7 13.8 16.6 14.5
Tobacco 77.8 76.9 78.9 73.8 77.5
Alcohol 86.9 90.4 86.2 92.9 88.1
Marijuana and hashish 46.5 28.8 40.4 40.5 40.4
Ecstasy 14.1 7.7 13.8 7.1 11.9
Amphetamines, pervitin 11.1 7.7 9.2 11.9 9.9
Cocaine 6.1 1.9 5.5 2.4 4.6
Heroin 4.0 1.9 1.8 7.1 3.3
LSD 5.1 3.8 3.7 7.1 4.6
Hallucinogenic mushrooms 7.1 1.9 4.6 7.1 5.3
Inhalants 4.0 5.8 2.8 9.5 4.6
Ketamine 4.0 1.9 1.8 7.1 3.3
Subutex ® 6.1 1.9 3.7 7.1 4.6
GHB 3.0 0 0.9 4.8 2.0
Poppers 6.1 1.9 3.7 7.1 4.6
The question about the use of new synthetic drugs (legal highs) was open-ended – all 151 users of new synthetic
drugs (NSDs) could state up to 10 NSDs that they had used, as it turned out that the way of inquiring about the use
of specific NSDs poses a complex methodological problem. The reasons are that:
NSDs and preparations which contain them are mostly supplied with no information about their composition;
the chemical names of NSDs are complicated for a non-professional and there are no generally accepted single
names (such as heroin or pervitin) for the substances under consideration;
the commercial names of NSDs vary and it is not clear which specific substances they are associated with, and
the market in NSDs may undergo changes in this respect.
page 34